Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

PHASE2RecruitingINTERVENTIONAL

Enrollment

138

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

March 31, 2027

Conditions

Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm

Interventions

DRUG

Fecal Microbiota Transplantation Capsule

Given PO

DRUG

Placebo

Given PO

Trial Locations (1)

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors

lead

Fred Hutchinson Cancer Center

OTHER